The role of 99mTc-ethambutol scintigraphy to diagnose pulmonary tuberculosis

Authors

  • Prayudi Santoso Respirology and Critical Illness Division, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia https://orcid.org/0000-0002-7182-386X
  • Basuki Hidayat Department of Nuclear Medicine and Theragnostics Molecular, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • Chica Pratiwi Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia https://orcid.org/0000-0002-3623-0954
  • Kevin Yonatan Budiman Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • Hari Soekersi Department of Radiology, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • Arto Yuwono Soeroto Respirology and Critical Illness Division, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia https://orcid.org/0000-0001-9027-2453

DOI:

https://doi.org/10.3855/jidc.15148

Keywords:

Tuberculosis, diagnostic test, 99mTc-ethambutol, scintigraphy

Abstract

Tuberculosis is a significant health problem in many parts of the world. According to the Global Tuberculosis Report 2020, 10 million new tuberculosis cases were reported worldwide in 2019, with only 57% of these cases being bacteriologically confirmed. Current tuberculosis diagnostic tests depend on the quality of the sputum, leaving many diagnostic uncertainties. Diagnostic delays result in ongoing transmission and more severe, progressive disease in the affected person. This shows that current diagnostic tests are not sufficient to establish all tuberculosis cases accurately, and there is a need for a new diagnostic technique. 99mTc-ethambutol scintigraphy was recently reported as a new diagnostic test for tuberculosis, with a sensitivity and specificity of 93.9% and 85.7%, respectively. Here, we report a case of the importance of this new technique for diagnosing tuberculosis when the existing bacteriological and molecular tests failed to confirm the diagnosis.

Author Biographies

Prayudi Santoso, Respirology and Critical Illness Division, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

Division of Respirology and Critical Illness Division, Department of Internal Medicine

Basuki Hidayat, Department of Nuclear Medicine and Theragnostics Molecular, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

Department of Nuclear Medicine and Molecular Medicine

Chica Pratiwi, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

Department of Internal Medicine

Hari Soekersi, Department of Radiology, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

Department of Radiology

Arto Yuwono Soeroto, Respirology and Critical Illness Division, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

Division of Respiratory and Critical Illness Medicine

Downloads

Published

2022-01-31

How to Cite

1.
Santoso P, Hidayat B, Pratiwi C, Budiman KY, Soekersi H, Soeroto AY (2022) The role of 99mTc-ethambutol scintigraphy to diagnose pulmonary tuberculosis. J Infect Dev Ctries 16:226–230. doi: 10.3855/jidc.15148

Issue

Vol. 16 No. 01: January 2022

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC